DALLAS, April 12, 2018 -- OTC PR Wire -- North American Cannabis Holdings, Inc. (USOTC:USMJ) today released a statement from the Company’s CEO, Steven Rash, after news breaks on former Republican House Speaker, John Boehner, announced that his “thinking on cannabis has evolved,” and joined the Board of Advisors of Acreage Holdings, a company that operates cannabis cultivation, processing and dispensing across 11 states. Boehner said: "I'm convinced de-scheduling the drug is needed so we can do research, help our veterans, and reverse the opioid epidemic ravaging our communities."
“The former Republican House Speaker’s very notable reversal on marijuana legalization is a strong signal that the pendulum is now swinging toward marijuana legalization,” said Steven Rash, CEO of North American Cannabis Holdings. “I share John Boehner’s journey in regard to his thinking on marijuana legalization. I’m just several years ahead of him. It was a veteran initiative that convinced me, and I also believe cannabis holds the key to reversing the opioid epidemic. I believe North American Cannabis Holdings has the experience and momentum to be a major player in the cannabis sector here as the pendulum starts to swing and accelerate the overall cannabis sector opportunity.”
North American Cannabis Holdings recently confirmed that company has received an unsolicited acquisition proposal. The company is entertaining the proposal and at the same time continuing forward momentum on its current business and developing opportunities.
For more information on North American Cannabis Holdings visit http://www.aciconglomerated.com/.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies' contracts, the companies' liquidity position, the companies' ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
For More Information, Contact:
Steven Rash
[email protected]
1-800-861-1350


SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation
Japan Earthquake Disrupts Auto and Chip Supply Chains
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 



